Contract HHSO100201100034C
Elusys Therapeutics Inc · Department Of Health And Human Services · August 30, 2011
Elusys Therapeutics Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on August 30, 2011 for $62.15 million of work in research and development in biotechnology. It was awarded under full and open competition. The contract has been modified 24 times since the base award It uses cost-plus contract pricing. The most recent modification was on August 6, 2024.
Contract details
- PIID
- HHSO100201100034C
- Award type
- —
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Research And Development Facilities
- First action
- August 30, 2011
- Latest action
- August 6, 2024
Description
THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO DE-OBLIGATE CANCELING FUNDS FROM REQUISITION OS212728 OF $282,172.97, UPDATE SECTION F.2. DELIVERABLES, AND G.5. INVOICES/FINANCING REQUEST AND CONTRAC
Modification timeline
-
August 6, 2024Mod P00024THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO DE-OBLIGATE CANCELING FUNDS FROM REQUISITION OS212728 OF $282,172.97, UPDATE SECTION F.2. DELIVERABLES, AND G.5$-282.2K
-
April 25, 2022Mod P00023TO OBLIGATE FUNDING FOR INDIRECT RATE ADJUSTMENTS FOR 2018, 2019, AND 2020.$912.3K
-
October 5, 2020Mod P00022ELUSYS 0034C MOD#0022 TO EXTEND POP TO 7/21/2021 AND ADD NEW SOW$0
-
September 9, 2020Mod P00021ELUSYS 0034C MOD#0020 TO EXTEND POP OF CLIN 5 TO 10/9/2020$0
-
September 4, 2020Mod P00020ELUSYS 0034C MOD#0020 TO EXTEND POP OF CLIN 6 TO 10/9/2020$0
-
June 16, 2020Mod P00019ELUSYS 0034C MOD#0019 TO EXTEND POP OF CLIN 6 TO 9/9/2020$0
-
November 21, 2019Mod P00018ELUSYS 0034C MOD#0018$0
-
March 1, 2019Mod 17ELUSYS 0034C MOD#0017$4.01M
-
December 17, 2018Mod 16ELUSYS 0034C MOD#0016$0
-
November 20, 2018Mod 15ELUSYS 0034C MOD#15$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSO100201100034C?
Contract HHSO100201100034C is a federal contract awarded to Elusys Therapeutics Inc by Department Of Health And Human Services on August 30, 2011 for $62.15 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 24 times since the base award.
Who won contract HHSO100201100034C?
Elusys Therapeutics Inc won contract HHSO100201100034C from Department Of Health And Human Services.
How much is contract HHSO100201100034C worth?
Contract HHSO100201100034C has obligated $62.15 million to date, with a total potential value of $69.59 million if all options are exercised.